Trial Profile
Placebo-controlled, randomized, blinded, double-dummy, crossover study to investigate the attenuation of ACTH activation induced by metyrapone with a single dose of GSK561679 or alprazolam in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Sep 2023
Price :
$35
*
At a glance
- Drugs Verucerfont (Primary) ; Alprazolam; Metyrapone
- Indications Mental disorders
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 10 May 2008 New trial record.